MedTrace Logo

Occlusion vs Standard Treatment for the Treatment of Herpes Zoster

NCT04258930 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-02-28

No results posted yet for this study

Summary

This study evaluates the addition of occlusive dressings (hydrocolloids) or topical silicone gel in the treatment of shingles (herpes zoster). One third of the participants will receive a hydrocolloid occlusive dressing, one third will receive the topical silicone gel and one third will receive the current treatment of the rash consisting of drying solutions (soaks).

Conditions

  • Herpes Zoster

Interventions

OTHER

Aluminum sulphate and calcium acetate drying soaks

Dilute one envelope of the powder in 500 ml of clean cold water and apply for 10 minutes every 8 hours until completely healed.

DEVICE

Topical sterile silicone gel for wounds

Apply a thick layer of silicone gel to all open areas every 8 hours until completely healed.

DEVICE

Hydrocolloid dressing

Apply enough hydrocolloid dressings to cover all open areas and change every 2 to 3 days once the dressing becomes saturated (starts to drain around the borders).

Sponsors & Collaborators

  • Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C.

    lead OTHER

Principal Investigators

  • Jose Contreras-Ruiz, MD · Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-26
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04258930 on ClinicalTrials.gov